Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
AstraZeneca
Medtronic
Express Scripts
Argus Health
McKesson
Cipla
Queensland Health
Julphar

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,014,867

« Back to Dashboard

Summary for Patent: 7,014,867
Title:Tablet comprising cetirizine and pseudoephedrine
Abstract:The present invention concerns a tablet comprising two distinct segments. More particularly, the invention relates to combinations of two pharmaceutical substances and methods of treatment of allergic disorders.
Inventor(s): Fanara; Domenico (Wanze, BE), Guichaux; Anthony (Fribourg, CH), Berwaer; Monique (Ham-sur-Heure-Nalinnes, BE), Deleers; Michel (Linkebeek, BE)
Assignee: UCB Farchim SA (Bulle, CH)
Application Number:10/481,264
Patent Claim Types:
see list of patent claims
Dosage form; Composition; Compound;

Drugs Protected by US Patent 7,014,867

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
J And J Consumer Inc ZYRTEC-D 12 HOUR cetirizine hydrochloride; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 021150-002 Nov 9, 2007 OTC Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,014,867

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
01115807Jun 28, 2001
PCT Information
PCT FiledJune 10, 2002PCT Application Number:PCT/EP02/06342
PCT Publication Date:January 09, 2003PCT Publication Number: WO03/002098

Non-Orange Book US Patents Family Members for Patent 7,014,867

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,226,614 Tablet comprising cetirizine and pseudoephedrine ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,014,867

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 1520285 ➤ Subscribe
China 100490809 ➤ Subscribe
Colombia 5540370 ➤ Subscribe
Costa Rica 7198 ➤ Subscribe
Cyprus 1109238 ➤ Subscribe
Czech Republic 20033454 ➤ Subscribe
Germany 60232445 ➤ Subscribe
Denmark 1404304 ➤ Subscribe
Estonia 200400005 ➤ Subscribe
Estonia 05357 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Fuji
Citi
Express Scripts
Medtronic
QuintilesIMS
Cantor Fitzgerald
Fish and Richardson
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot